Cytokine Release Syndrome caused by CAR-T Cell Therapy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06273 | Tocilizumab | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06273 | Tocilizumab | Interleukin-6 receptor subunit alpha | target |
| DB06273 | Tocilizumab | Cytochrome P450 3A4 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|